184 related articles for article (PubMed ID: 17519353)
1. The Janus kinase 2 is required for expression and nuclear accumulation of cyclin D1 in proliferating mammary epithelial cells.
Sakamoto K; Creamer BA; Triplett AA; Wagner KU
Mol Endocrinol; 2007 Aug; 21(8):1877-92. PubMed ID: 17519353
[TBL] [Abstract][Full Text] [Related]
2. A non-catalytic function of the Src family tyrosine kinases controls prolactin-induced Jak2 signaling.
García-Martínez JM; Calcabrini A; González L; Martín-Forero E; Agulló-Ortuño MT; Simon V; Watkin H; Anderson SM; Roche S; Martín-Pérez J
Cell Signal; 2010 Mar; 22(3):415-26. PubMed ID: 19892015
[TBL] [Abstract][Full Text] [Related]
3. Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice.
Wagner KU; Krempler A; Triplett AA; Qi Y; George NM; Zhu J; Rui H
Mol Cell Biol; 2004 Jun; 24(12):5510-20. PubMed ID: 15169911
[TBL] [Abstract][Full Text] [Related]
4. Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways.
Neilson LM; Zhu J; Xie J; Malabarba MG; Sakamoto K; Wagner KU; Kirken RA; Rui H
Mol Endocrinol; 2007 Sep; 21(9):2218-32. PubMed ID: 17550976
[TBL] [Abstract][Full Text] [Related]
5. PRL activates the cyclin D1 promoter via the Jak2/Stat pathway.
Brockman JL; Schroeder MD; Schuler LA
Mol Endocrinol; 2002 Apr; 16(4):774-84. PubMed ID: 11923474
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia activates the cyclin D1 promoter via the Jak2/STAT5b pathway in breast cancer cells.
Joung YH; Lim EJ; Lee MY; Park JH; Ye SK; Park EU; Kim SY; Zhang Z; Lee KJ; Park DK; Park T; Moon WK; Yang YM
Exp Mol Med; 2005 Aug; 37(4):353-64. PubMed ID: 16155412
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5).
Friedrichsen BN; Galsgaard ED; Nielsen JH; Møldrup A
Mol Endocrinol; 2001 Jan; 15(1):136-48. PubMed ID: 11145745
[TBL] [Abstract][Full Text] [Related]
8. Src mediates prolactin-dependent proliferation of T47D and MCF7 cells via the activation of focal adhesion kinase/Erk1/2 and phosphatidylinositol 3-kinase pathways.
Acosta JJ; Muñoz RM; González L; Subtil-Rodríguez A; Dominguez-Caceres MA; García-Martínez JM; Calcabrini A; Lazaro-Trueba I; Martín-Pérez J
Mol Endocrinol; 2003 Nov; 17(11):2268-82. PubMed ID: 12907754
[TBL] [Abstract][Full Text] [Related]
9. Janus kinase 2 (JAK2) regulates prolactin-mediated chloride transport in mouse mammary epithelial cells through tyrosine phosphorylation of Na+-K+-2Cl- cotransporter.
Selvaraj NG; Omi E; Gibori G; Rao MC
Mol Endocrinol; 2000 Dec; 14(12):2054-65. PubMed ID: 11117534
[TBL] [Abstract][Full Text] [Related]
10. The protein tyrosine phosphatase-PEST is implicated in the negative regulation of epidermal growth factor on PRL signaling in mammary epithelial cells.
Horsch K; Schaller MD; Hynes NE
Mol Endocrinol; 2001 Dec; 15(12):2182-96. PubMed ID: 11731619
[TBL] [Abstract][Full Text] [Related]
11. Jak2 is an essential tyrosine kinase involved in pregnancy-mediated development of mammary secretory epithelium.
Shillingford JM; Miyoshi K; Robinson GW; Grimm SL; Rosen JM; Neubauer H; Pfeffer K; Hennighausen L
Mol Endocrinol; 2002 Mar; 16(3):563-70. PubMed ID: 11875116
[TBL] [Abstract][Full Text] [Related]
12. Stat5 promotes survival of mammary epithelial cells through transcriptional activation of a distinct promoter in Akt1.
Creamer BA; Sakamoto K; Schmidt JW; Triplett AA; Moriggl R; Wagner KU
Mol Cell Biol; 2010 Jun; 30(12):2957-70. PubMed ID: 20385773
[TBL] [Abstract][Full Text] [Related]
13. The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways.
D'Amico M; Hulit J; Amanatullah DF; Zafonte BT; Albanese C; Bouzahzah B; Fu M; Augenlicht LH; Donehower LA; Takemaru K; Moon RT; Davis R; Lisanti MP; Shtutman M; Zhurinsky J; Ben-Ze'ev A; Troussard AA; Dedhar S; Pestell RG
J Biol Chem; 2000 Oct; 275(42):32649-57. PubMed ID: 10915780
[TBL] [Abstract][Full Text] [Related]
14. PAK1-Nck regulates cyclin D1 promoter activity in response to prolactin.
Tao J; Oladimeji P; Rider L; Diakonova M
Mol Endocrinol; 2011 Sep; 25(9):1565-78. PubMed ID: 21719533
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end product-induced proliferation in NRK-49F cells is dependent on the JAK2/STAT5 pathway and cyclin D1.
Guh JY; Huang JS; Chen HC; Hung WC; Lai YH; Chuang LY
Am J Kidney Dis; 2001 Nov; 38(5):1096-104. PubMed ID: 11684565
[TBL] [Abstract][Full Text] [Related]
16. Janus kinase 2 is required for the initiation but not maintenance of prolactin-induced mammary cancer.
Sakamoto K; Triplett AA; Schuler LA; Wagner KU
Oncogene; 2010 Sep; 29(39):5359-69. PubMed ID: 20639901
[TBL] [Abstract][Full Text] [Related]
17. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
18. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
[TBL] [Abstract][Full Text] [Related]
19. LPS-induced SOCS3 antagonizes the JAK2-STAT5 pathway and inhibits β-casein synthesis in bovine mammary epithelial cells.
Geng Z; Shan X; Lian S; Wang J; Wu R
Life Sci; 2021 Aug; 278():119547. PubMed ID: 33930363
[TBL] [Abstract][Full Text] [Related]
20. Prolactin signals via Stat5 and Oct-1 to the proximal cyclin D1 promoter.
Brockman JL; Schuler LA
Mol Cell Endocrinol; 2005 Jul; 239(1-2):45-53. PubMed ID: 15885880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
